Zobrazeno 1 - 10
of 106
pro vyhledávání: '"S. M. Lippman"'
Publikováno v:
Chest. 103:15S-19
Publikováno v:
JNCI Journal of the National Cancer Institute. 91:563-565
Re: Cancer Chemoprevention: Progress and Promise The commentary by Lippman et al. (1) provides a useful review of the topic by organizing a massive amount of in- formation in an organized way. How- ever, because this review will be widely read and re
Autor:
S M, Lippman, M R, Spitz
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19
Lung cancer is the leading cause of cancer deaths in the United States and the world, with grim incidence and mortality figures underscoring the need for new approaches, such as chemoprevention, for controlling this disease. There have been definitiv
Autor:
A, Hoque, D, Albanes, S M, Lippman, M R, Spitz, P R, Taylor, E A, Klein, I M, Thompson, P, Goodman, J L, Stanford, J J, Crowley, C A, Coltman, R M, Santella
Publikováno v:
Cancer causescontrol : CCC. 12(7)
To conduct timely epidemiologic investigations of molecular/genetic markers that may contribute to the development of prostate, lung, colorectal, or other cancers within the Selenium and Vitamin E Cancer Prevention Trial (SELECT), and to evaluate int
Publikováno v:
The Journal of urology. 166(4)
Growing evidence implies that selenium and vitamin E may decrease the risk of prostate cancer. The Selenium and Vitamin E Cancer Prevention Trial (SELECT) is a randomized prospective double-blind study designed to determine whether selenium and vitam
Autor:
F R, Khuri, E S, Kim, J J, Lee, R J, Winn, S E, Benner, S M, Lippman, K K, Fu, J S, Cooper, E E, Vokes, R M, Chamberlain, B, Williams, T F, Pajak, H, Goepfert, W K, Hong
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 10(8)
Second primary tumors (SPTs) develop at an annual rate of 3-7% in patients with head and neck squamous cell cancer (HNSCC). In a previous Phase III study, we observed that high doses of 13-cis-retinoic acid reduced the SPT rate in this disease. In 19
Publikováno v:
Analytical and quantitative cytology and histology. 23(3)
To develop and determine the staining protocols and computerized image analysis methods that are the most effective combination for performing quantitative analysis of Ki-67.We compared conventional bright-field light microscopy and refractive optica
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 10(6)
The synthetic retinoid, N-(4-hydroxyphenyl)retinamide (4HPR), which is currently being evaluated in clinical trials for cancer prevention and therapy, inhibits the growth of a variety of malignant cells through induction of apoptosis. However, in the
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 10(6)
Head and neck cancer develops in a multistep process and is associated with increasing frequencies of p53 alterations and with increasing genomic instability. To study the relationship of p53 alterations and genomic instability during head and neck t
Autor:
X C, Xu, W Y, Wong, L, Goldberg, S C, Baer, J E, Wolf, W M, Ramsdell, D S, Alberts, S M, Lippman, R, Lotan
Publikováno v:
Cancer research. 61(11)
Retinoids are essential for normal skin growth, differentiation, and apoptosis and are active pharmacologically in the prevention and treatment of skin cancers and other lesions. Retinoid effects are mediated mainly by retinoic acid receptors (RARs)